| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6243133 | European Journal of Radiology | 2014 | 30 Pages |
Abstract
Characterization of non-enhancing hyperintense FLAIR lesion area in GB patients can provide an MR-based biomarker, indicating a shift to an infiltrative progression pattern, and may improve therapy response assessment in patients following bevacizumab therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Moran Artzi, Felix Bokstein, Deborah T. Blumenthal, Orna Aizenstein, Gilad Liberman, Benjamin W. Corn, Dafna Ben Bashat,